← All trials
NCT00707122
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2008
- Primary completion
- Apr 30, 2013
- Completion date
- Oct 31, 2013
- First posted
- Jun 30, 2008
- Last posted
- Nov 10, 2015
- Enrollment
- 1818
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- A.O. Ospedale Maggiore di LodiLead sponsor
- Mario Negri InstituteStudy chair
- Mario Negri InstituteOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.